Dan Troy is a globally recognized healthcare lawyer and accomplished executive whose career has spanned leadership positions in the life sciences, legal, and regulatory sectors. His past experience includes working as chief counsel for the US Food and Drug Administration (FDA), general counsel at multinational life sciences and technology companies, and partner at preeminent law firms.

Previously, Mr. Troy worked as a global general counsel at a multinational pharmaceutical and biotechnology company for ten years. He employed hands-on and practical approaches to creatively resolve major issues, manage risks, and achieve critical strategic goals. He led and managed a global team of over 630 professionals, including more than 400 attorneys, across more than fifty countries.

Mr. Troy is a highly sought thought leader, having served as chief counsel of the FDA, chaired the US Chamber Litigation Center, and led influential committees and sections within organizations such as the American Bar Association and the American Law Institute. He was named a “Legend in the Law” at the 2013 Burton Awards and selected in the Financial Times (FT) Global General Counsel 30 in 2016.

Mr. Troy is a seasoned executive and respected board member with extensive expertise in corporate governance, dispute resolution, and regulatory compliance. He is known for innovative litigation resolution and a cutting-edge approach to advising businesses. He combines exceptional technical legal skills honed over more than thirty years in private and governmental sectors with sound business judgment to drive success in complex and high-profile environments.

Employment History

Valo Health, LLC
Executive Vice President and General Counsel

NeuroRx, Inc
Board Member

GlaxosmithKline, PLC
General Counsel

Professional Affiliations

American Law Institute (ALI), Member

American Bar Association, Member

American Enterprise Institute, Associate Scholar

Areas of Expertise


Columbia University
JD, 1983

Cornell University
BS, Industrial and Labor Relations, 1980